Matches in Nanopublications for { ?s ?p "[Recently, it has become clear that patients meeting WHO criteria for RARS-T have clonal JAK2(V617F) and MPL(W515) mutations at a similar rate to essential thrombocythaemia (ET).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP171618.RAih6gPrm1tExOkJ2rPN1ZGAfBxJ6knW1GdurSFVfG-Qo130_assertion description "[Recently, it has become clear that patients meeting WHO criteria for RARS-T have clonal JAK2(V617F) and MPL(W515) mutations at a similar rate to essential thrombocythaemia (ET).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP171618.RAih6gPrm1tExOkJ2rPN1ZGAfBxJ6knW1GdurSFVfG-Qo130_provenance.
- NP442875.RA85xvgu_8Ir2cSpgC0zMuEHHvY0d-m3DAZYraxbjj7wo130_assertion description "[Recently, it has become clear that patients meeting WHO criteria for RARS-T have clonal JAK2(V617F) and MPL(W515) mutations at a similar rate to essential thrombocythaemia (ET).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP442875.RA85xvgu_8Ir2cSpgC0zMuEHHvY0d-m3DAZYraxbjj7wo130_provenance.
- NP912921.RA-vPk5FFxDfjqsXdayq97tHCUTlixgxAXoHkz-PiC-7w130_assertion description "[Recently, it has become clear that patients meeting WHO criteria for RARS-T have clonal JAK2(V617F) and MPL(W515) mutations at a similar rate to essential thrombocythaemia (ET).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP912921.RA-vPk5FFxDfjqsXdayq97tHCUTlixgxAXoHkz-PiC-7w130_provenance.
- assertion description "[Recently, it has become clear that patients meeting WHO criteria for RARS-T have clonal JAK2(V617F) and MPL(W515) mutations at a similar rate to essential thrombocythaemia (ET).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Recently, it has become clear that patients meeting WHO criteria for RARS-T have clonal JAK2(V617F) and MPL(W515) mutations at a similar rate to essential thrombocythaemia (ET).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Recently, it has become clear that patients meeting WHO criteria for RARS-T have clonal JAK2(V617F) and MPL(W515) mutations at a similar rate to essential thrombocythaemia (ET).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP712185.RAa8Da6UxCHzaWQGtROmcKk9JJ4yQsNH6ctskCiQL6Z1Y130_assertion description "[Recently, it has become clear that patients meeting WHO criteria for RARS-T have clonal JAK2(V617F) and MPL(W515) mutations at a similar rate to essential thrombocythaemia (ET).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP712185.RAa8Da6UxCHzaWQGtROmcKk9JJ4yQsNH6ctskCiQL6Z1Y130_provenance.
- NP712188.RALBjvdOu0bnDwFN0Q1gtnSy6z_njCEXLuQ3qOjGVWH5E130_assertion description "[Recently, it has become clear that patients meeting WHO criteria for RARS-T have clonal JAK2(V617F) and MPL(W515) mutations at a similar rate to essential thrombocythaemia (ET).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP712188.RALBjvdOu0bnDwFN0Q1gtnSy6z_njCEXLuQ3qOjGVWH5E130_provenance.
- NP712181.RAw8LxVeWom8RhLzMBZ5aZM6GrYS2fAxoyvFHuiwwU4fI130_assertion description "[Recently, it has become clear that patients meeting WHO criteria for RARS-T have clonal JAK2(V617F) and MPL(W515) mutations at a similar rate to essential thrombocythaemia (ET).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP712181.RAw8LxVeWom8RhLzMBZ5aZM6GrYS2fAxoyvFHuiwwU4fI130_provenance.